Urinary Tobacco and Nicotine Exposure Biomarkers as Predictors of Transitions between Cigarette and e-Cigarette Use in the Exhale Longitudinal Cohort Study
Nicotine and Tobacco Research · 2026
DOI: 10.1093/ntr/ntaf173 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Nicotine and Tobacco Research, 2026. Verfasst von Andrew F Brouwer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, University of Michigan, 1415 Washington Heights, Ann Arbor, MI 48109, USA. Hauptthemen laut MEDLINE: Nicotine, Electronic Nicotine Delivery Systems, Cigarette Smoking, Vaping. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, NCI NIH HHS, NCRR NIH HHS.
Abstract (Originalsprache)
Introduction
Urinary tobacco and nicotine exposure biomarkers may be predictive of subsequent transitions in product use.
Methods
We used data from an observational study of 371 adults who smoked cigarettes daily, some of whom also used e-cigarettes, and who were followed every 2 months for up to 2 years (Wisconsin, United States, 2015–2019). Using a multistate transition model, we assessed continuous associations between transition propensities and urinary tobacco biomarker concentrations, namely 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol) (NNAL) and NE-2 (cotinine + trans-3’-hydroxycotinine), the nicotine metabolite ratio (NMR; trans-3’-hydroxycotinine:cotinine), and NNAL:NE-2, measured every 4 months.
Results
The biomarkers were generally more predictive of transitions from dual use, but not from cigarette-only use, than self-reported product use was. Propensity to stop smoking cigarettes decreased with increasing concentrations of NNAL and NE-2, for both participants who smoked only cigarettes and those who used both cigarettes and e-cigarettes. For example, we estimated that, at 20 pg NNAL per mg creatinine, 30.2% (95% CI = 14.6%, 47.0%) of those who only smoke cigarettes and 26.6% (95% CI = 11.3%, 42.5%) who dual use would transition to non-current cigarette use and e-cigarette use in 1 year, while at the 200 pg/ng, we estimate these probabilities to be 3.2% (95% CI = 1.7%, 5.8%) and 3.9% (95% CI = 1.9%, 8.5%), respectively. The ratio NNAL:NE-2 was predictive of transitions from dual use to cigarette-only (higher ratio) or e-cigarette-only (lower ratio) use.
Conclusions
Urinary tobacco biomarkers were non-linearly associated with transitions in tobacco product use and may guide the development of clinical interventions to promote harm-reducing product use transitions.
Implications
This work may inform the development of clinical interventions to promote harm-reducing product use transitions by using urine testing that more sensitively reflects product exposure than self-reported product use. Additionally, regulations restricting nicotine concentration in cigarettes or e-cigarettes may affect individuals’ biomarker levels. By understanding how different biomarker levels are differentially associated with transition propensities, we can help to contribute to impact analysis of potential nicotine limiting regulations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, University of Michigan, 1415 Washington Heights, Ann Arbor, MI 48109, USA.
- Department of Biostatistics, Boston University, 715 Albany Street, Boston, MA 02118, USA.
- Department of Medicine, University of California San Francisco, 2540 23rd Street, San Francisco, CA 94110, USA.
- Department of Medicine, University of Wisconsin, 1930 Monroe Street, Madison, WI 53711, USA.
ORCID-Profile: Andrew F Brouwer, Neal Benowitz, Megan E Piper
Förderung
- NIDA NIH HHS
- NCI NIH HHS
- NCRR NIH HHS
- National Institutes of Health and Food and Drug Administration
- National Institutes of Health Analytical Chemistry Resource
Zitieren
APA
Brouwer, A. F., Shafie-Khorassani, F., Benowitz, N., Shi, N., Baker, T. B., Hayes-Birchler, T., & Piper, M. E. (2026). Urinary Tobacco and Nicotine Exposure Biomarkers as Predictors of Transitions between Cigarette and e-Cigarette Use in the Exhale Longitudinal Cohort Study. Nicotine and Tobacco Research. https://doi.org/10.1093/ntr/ntaf173
Vancouver
Brouwer AF, Shafie-Khorassani F, Benowitz N, Shi N, Baker TB, Hayes-Birchler T, et al. Urinary Tobacco and Nicotine Exposure Biomarkers as Predictors of Transitions between Cigarette and e-Cigarette Use in the Exhale Longitudinal Cohort Study. Nicotine and Tobacco Research. 2026. doi:10.1093/ntr/ntaf173
BibTeX
@article{Brouwer2026,
author = {Brouwer, Andrew F and Shafie-Khorassani, Fatema and Benowitz, Neal and Shi, Nan and Baker, Timothy B and Hayes-Birchler, Todd and Piper, Megan E},
title = {Urinary Tobacco and Nicotine Exposure Biomarkers as Predictors of Transitions between Cigarette and e-Cigarette Use in the Exhale Longitudinal Cohort Study},
journal = {Nicotine and Tobacco Research},
year = {2026},
doi = {10.1093/ntr/ntaf173}
}
EUVIMED